DATADRIVENPHARMA Trademark

Trademark Overview

On Wednesday, March 19, 2025, a trademark application was filed for DATADRIVENPHARMA with the United States Patent and Trademark Office. The USPTO has given the DATADRIVENPHARMA trademark a serial number of 99092945. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, May 5, 2026. This trademark is owned by Data Driven Pharma LLC. The DATADRIVENPHARMA trademark is filed in the Advertising, Business and Retail Services category with the following description:

Organizing business networking events in the field of pharmaceuticals and biotechnology; Business networking
datadrivenpharma

General Information

Serial Number99092945
Word MarkDATADRIVENPHARMA
Filing DateWednesday, March 19, 2025
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateTuesday, May 5, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesOrganizing business networking events in the field of pharmaceuticals and biotechnology; Business networking

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, March 19, 2025
Primary Code035
First Use Anywhere DateWednesday, July 24, 2024
First Use In Commerce DateWednesday, July 24, 2024

Trademark Owner History

Party NameData Driven Pharma LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWalnut Creek, CA 94597
US

Trademark Events

Event DateEvent Description
Wednesday, March 19, 2025NEW APPLICATION ENTERED
Wednesday, March 19, 2025APPLICATION FILING RECEIPT MAILED
Thursday, July 10, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 19, 2025ASSIGNED TO EXAMINER
Wednesday, September 3, 2025NON-FINAL ACTION WRITTEN
Wednesday, September 3, 2025NON-FINAL ACTION E-MAILED
Wednesday, September 3, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 8, 2025TEAS PETITION TO REVIVE RECEIVED
Monday, December 8, 2025PETITION TO REVIVE-GRANTED
Monday, December 8, 2025NOTICE OF REVIVAL - E-MAILED
Monday, December 8, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 8, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 8, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 2, 2026ASSIGNED TO EXAMINER
Thursday, February 5, 2026NON-FINAL ACTION WRITTEN
Thursday, February 5, 2026NON-FINAL ACTION E-MAILED
Thursday, February 5, 2026NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 5, 2026TEAS REQUEST TO DIVIDE RECEIVED
Tuesday, May 5, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 5, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 5, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 14, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 5, 2026DIVISIONAL REQUEST RECEIVED
Tuesday, May 19, 2026DIVISIONAL PROCESSING COMPLETE

Related Keywords

datadrivenpharma networking business biotechnology pharmaceuticals events organizing field